Articles written by Fermín Orgambide - Benzinga

Patents In The Psychedelics Space: Good Or Bad? It's Complicated, Here's What The Experts Say

Patents are the golden eggs of the booming psychedelic space.

Massachusetts Marijuana Sales Surpass $3 Billion, According To Cannabis Control Commission

In a press release, the Massachusetts Cannabis Control Commission reported that adult-use marijuana sales have officially surpassed $3 billion.

Gavin Newsom's Cannabis Tax-Cut Proposal: Industry Leaders Complain It Doesn't Fix Key Problems

Although California Governor Gavin Newsom’s proposal of eliminating cannabis cultivation taxes has received a lot of support, it also has its detractors.

Awakn's Study On Psychedelics For Treating Addiction Shows Promise, Will Undertake Broader Research

Awakn Life Sciences (OTCQB: AWKNF) has announced the successful completion of the first ketamine study for a varied set of behavioral addictions.

MindMed Reports Promising Results For Non-Hallucinogenic Ibogaine Congener Substance

MindMed Inc. (NASDAQ: MNMD) reported favorable results for one of its proprietary compounds.

Novamind To Offer Ketamine Treatment To Frontline Workers Who Suffer Pandemic-Related Distress

After a period of clinical pilot, Novamind Inc. (OTCQB: NVMDF) will offer Frontline KAP, group-based ketamine-assisted psychotherapy or KAP, for frontline workers, at some of its clinics.

CSIRO, Australia's National Science Agency, Gets In The Psychedelics Space

It’s not every day that a country’s national institute makes public its efforts to get into psychedelics, but today is one of those days.

EXCLUSIVE: Bexson Biomedical's CSO Says Subcutaneous Ketamine Could Treat Wide Range Of Health Issues

Bexson Biomedical recently signed a deal with the Stevanato Group to develop a subcutaneous delivery system of ketamine.

Licensed Cultivator Selling Marijuana On Facebook Caught By Police, 22,000 Plants Destroyed

The Humboldt County Sheriff’s Office caught a licensed cannabis cultivator selling marijuana clones on Facebook's Marketplace to unlicensed buyers.

Optimi Health Adds Large Portfolio Of Magic Mushrooms Strains To Its Genetic Bank

Optimi Health Corp (OTCQX: OPTHF) acquired thirty-three types of psilocybin and mushroom strains intended for cultivation.

Psychedelics Retreats Coming To Canada Could Soon Offer Psilocybin Treatment

The investment issuer Origin Therapeutics Holdings announced that one of its companies will offer its first psychedelic retreat. The service will be offered by one of its portfolio companies, Dimensions Health Centres Inc. North of Toronto, Dimensions Algonquin Highlands will host group retreats starting this July.

Numinus Granted Canada's Special Access Program For Magic Mushrooms To Treat Life-Threatening Conditions

Numinus Wellness Inc (OTCQB: NUMIF) has been approved to use psilocybin-assisted therapy through Health Canada’s Special Access Program (SAP), marking the first instance in which Numinus will provide this treatment outside of a clinical trial.

Irwin Naturals Continues To Expand In Psychedelics Space, Acquires New Ketamine Clinic

Irwin Naturals (OTCQB: IWINF) has acquired a new healthcare clinic

Red Light Holland Sends Magic Mushrooms Into Canada To Be Used As Pharmaceutical Ingredients

Red Light Holland (OTCPK:TRUFF) has announced the successful export of psilocybin truffles to its partner in Canada, CCrest Laboratories, through a permit given by Health Canada.

MindMed Reports Financial Results For Q1, With Lower Cash Balance Compared To December Last Year

MindMed (NASDAQ: MNMD) announced its financial results for the first quarter of 2022, which ended March 31.

Beckley Retreats Launches To Offer Magic Mushroom Retreats In Jamaica

Following Silo Wellness’ (OTCQB: SILFF) steps, the newly launched Beckley Retreats

Has Clearmind Developed A Psychedelics-Based Drug That Can Treat Alcoholism? The FDA Is Interested

On Wednesday, May 18, Clearmind Medicine Inc. (OTC Pink: CMNDF) will meet with the Center for Drug Evaluation and Research (CDER), a department within the FDA.

Irwin Naturals And Assurance Laboratories Reach Licensing Agreement For THC Products In New Mexico

After inking a deal with The Hive Laboratory last month, Irwin Naturals Inc.

Veterans In Arizona Will Have Access To Ketamine Therapy At No Out-Of-Pocket Cost

Delic Holdings Corp’s (OTCQB: DELCF) Ketamine Wellness Center will provide military veterans in Arizona with ketamine therapy for treatment-resistant depression (TRD) and PTSD.

Colorado Activists Push To Add Psychedelics Reform Onto November Ballot

Activists with the Natural Medicine Colorado campaign say they've collected nearly half the signatures needed to get psychedelics reform on the November ballot.